,

Qiu-Yi Tang1,2,3,4, Yi-Jian Zhang1,2,3,4, Zi-You Wu5

  • 1Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

概括

新辅助化疗免疫疗法 (NAT) 通过重塑瘤微环境 (TME) 对晚期胆囊癌 (GBC) 呈现有前途的前景. 这种治疗扩大了有益的免疫细胞,减少了促进瘤的元素,提供了新的治疗策略.